(Q83150534)
Statements
Efficacy and safety of adalimumab in patients with psoriasis previously treated with anti-tumour necrosis factor agents: subanalysis of BELIEVE (English)
J-P Ortonne
S Chimenti
K Reich
P Sprøgel
K Unnebrink
H Kupper
O Goldblum
9 January 2011